Pamorelin LA 3.75 mg
Pamorelin LA 3.75 mg is a medicine authorised by Swissmedic under authorisation number 52815. The authorisation holder is Debiopharm Research & Manufacturing SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 January 1998 and the authorisation is valid without a time limit. ATC code L02AE04 places the medicine in the group Endocrine therapy.
| Authorisation number | 52815 |
|---|---|
| Name | Pamorelin LA 3.75 mg |
| Full name | Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée |
| Authorisation holder | Debiopharm Research & Manufacturing SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L02AE04 |
| First authorisation | 14 January 1998 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée | A | 14 January 1998 |
| 2 | Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée | A | 07 September 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 29 | 1 | Set | L02AE04 | 07.16.2. | A |
| 1 | 1 | Set | L02AE04 | 07.16.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pamorelin LA 3.75 mg authorised in Switzerland?
Yes. Pamorelin LA 3.75 mg is authorised by Swissmedic under authorisation number 52815, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pamorelin LA 3.75 mg have?
Pamorelin LA 3.75 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pamorelin LA 3.75 mg?
The authorisation holder is Debiopharm Research & Manufacturing SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.